HD Immune GmbH Foundation and Publication of Latest PreClinical Data
HD Immune GmbH HDI a privately held biotechnology company developing novel antibody treatments for Huntingtons Disease announces commencement of operations by its two founders Dr. Stefan Bartl and Dr. Lionel Wightman.